Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study

BACKGROUND/AIMS: This study assessed the efficacy and safety of high-dose multimatrix mesalazine once-daily (QD) compared to another form of high-dose mesalazine. METHODS: In this multicenter, randomized, double-blind study, 280 patients with mildly to moderately active ulcerative colitis (UC) recei...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Intest Res
Glavni autori: Ogata, Haruhiko, Aoyama, Nobuo, Mizushima, Seiichi, Hagino, Atsushi, Hibi, Toshifumi
Format: Artigo
Jezik:Inglês
Izdano: Korean Association for the Study of Intestinal Diseases 2017
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5478762/
https://ncbi.nlm.nih.gov/pubmed/28670234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2017.15.3.368
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items